Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Bicara Therapeutics Inc. | 0 | 2,204,650 | +2,204,650 | 0 | 56,152 | 35.09% | +56,152 |
| Replimune Group(REPL) | 2,461,319 | 2,461,319 | 0 | 22,152 | 26,976 | 16.86% | +4,824 |
| Immunic Inc(IMUX) | 1,788,160 | 1,788,160 | 0 | 1,985 | 2,950 | 1.84% | +966 |
| enGene Holdings Inc. *W EXP 10/31/202 | 321,502 | 321,502 | 0 | 383 | 675 | 0.42% | +293 |
| Ikena Oncology | 2,249,123 | 2,249,123 | 0 | 3,711 | 3,891 | 2.43% | +180 |
| Syros Pharmaceuticals | 251,270 | 251,270 | 0 | 1,297 | 540 | 0.34% | -756 |
| Sana Biotechnology, Inc.(SANA) | 843,750 | 843,750 | 0 | 4,607 | 3,510 | 2.19% | -1,097 |
| Alumis Inc | 653,225 | 653,223 | -2 | 8,688 | 6,976 | 4.36% | -1,711 |
| enGene Holdings Inc. COM | 1,076,357 | 1,076,357 | 0 | 10,150 | 7,104 | 4.44% | -3,046 |
| Morphic Holding | 159,846 | 0 | -159,846 | 5,446 | 0 | — | -5,446 |
| Nuvation Bio(NUVB) | 13,275,884 | 13,072,340 | -203,544 | 38,766 | 29,936 | 18.71% | -8,830 |
| Lexeo Therapeutics(LXEO) | 2,355,904 | 2,355,904 | 0 | 37,789 | 21,297 | 13.31% | -16,491 |